✦ LIBER ✦

3612 POSTER Cost Utility Analysis of Modified FLOX as First Line Chemotherapy for Metastatic Colorectal Cancer

✍ Scribed by M.P. Mak; F.H. Souza; D.R. Nebuloni; D.F. Saragiotto; G. Castro Jr.; J. Sabbaga; P.M. Hoff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3604 POSTER First-line Bevacizumab Plus

✍ F. Compagnat; V. Nerich; F. Bazan; A. Voidey; C. Villanueva; E. Dobi; A. Thiery- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

PCN8: COST-UTILITY ANALYSIS OF SEVERAL S

✍ CA Uyl-de Groot; N Li; M van Agthoven; P Willemse 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN71 Cost-Effectiveness Analysis of Cet

✍ V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ibáñez de Cáceres; Á 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

616 POSTER Safety analysis of first-line

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

3061 POSTER Phase I/II study of novel or

✍ M. Tahara; Y. Yamada; A. Ohtsu; K. Shirao; Y. Shimada; Y. Sasaki; W. Yamamoto; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A systematic review of FOLFOXIRI chemoth

✍ F. Montagnani; A. Chiriatti; G. Turrisi; G. Francini; G. Fiorentini 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB